| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Fraser Laboratories, McGill University and Royal Victoria Hospital [M. T., K. S., D. L., C. B. S.], and Pharmaceutical Sector, Biotechnology Research Institute, National Research Council of Canada [S-H. S.], Montreal, Quebec, H3A 1A1 Canada
The G protein-coupled receptor agonist somatostatin (SST)-induces apoptosis in MCF-7 human breast cancer cells. This is associated with induction of wild-type p53, Bax, and an acidic endonuclease. We have shown recently that its cytotoxic signaling is mediated via membrane-associated SHP-1 and is dependent on decrease in intracellular pH (pHi) to 6.5. Here we investigated the relationship between intracellular acidification and SHP-1 in cytotoxic signaling. Clamping of pHi at 7.25 by the proton-ionophore nigericin abolished SST-signaled apoptosis without affecting its ability to regulate SHP-1, p53, and Bax. Apoptosis could be induced by nigericin clamping of pHi to 6.5. Such acidification-induced apoptosis was not observed at pHi <6.0 or >6.7. pHi-dependent apoptosis was associated with the translocation of SHP-1 to the membrane, enhanced in cells overexpressing SHP-1, and was abolished by its inactive mutant SHP-1C455S. Acidification caused by inhibition of Na+/H+ exchanger and H+ ATPase (pHi = 6.55 and 6.65, respectively) also triggered apoptosis. The effect of concurrent inhibition of Na+/H+ exchanger and H+-ATPase on pHi and apoptosis was comparable with that of SST. Acidification-induced, SHP-1-dependent apoptosis occurred in breast cancer cell lines in which SST was cytotoxic (MCF-7 and T47D) or not (MDA-MB-231). We conclude that: (a) SST-induced SHP-1-dependent acidification occurs subsequent to or independent of the induction of p53 and Bax; (b) SST-induced intracellular acidification may arise due to inhibition of Na+/H+ exchanger and H+-ATPase; and (c) SHP-1 is necessary not only for agonist-induced acidification but also for the execution of acidification-dependent apoptosis. We suggest that combined targeting of SHP-1 and intracellular acidification may lead to a novel strategy of anticancer therapy bypassing the need for receptor-mediated signaling.
This article has been cited by other articles:
![]() |
S. HARGUINDEY, J. L. ARRANZ, M. L. WAHL, G. ORIVE, and S. J. RESHKIN Proton Transport Inhibitors as Potentially Selective Anticancer Drugs Anticancer Res, June 1, 2009; 29(6): 2127 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xue, D. Zhou, H. Yao, O. Gavrialov, M. J. McConnell, B. D. Gelb, and G. G. Haddad Novel functional interaction between Na+/H+ exchanger 1 and tyrosine phosphatase SHP-2 Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2406 - R2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kokkonen, A. Rivinoja, A. Kauppila, M. Suokas, I. Kellokumpu, and S. Kellokumpu Defective Acidification of Intracellular Organelles Results in Aberrant Secretion of Cathepsin D in Cancer Cells J. Biol. Chem., September 17, 2004; 279(38): 39982 - 39988. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Reshkin, A. Bellizzi, R. A. Cardone, M. Tommasino, V. Casavola, and A. Paradiso Paclitaxel Induces Apoptosis via Protein Kinase A- and p38 Mitogen-activated Protein-dependent Inhibition of the Na+/H+ Exchanger (NHE) NHE Isoform 1 in Human Breast Cancer Cells Clin. Cancer Res., June 1, 2003; 9(6): 2366 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pang, S. Wakabayashi, and M. Shigekawa Expression of Calcineurin B Homologous Protein 2 Protects Serum Deprivation-induced Cell Death by Serum-independent Activation of Na+/H+ Exchanger J. Biol. Chem., November 8, 2002; 277(46): 43771 - 43777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yusta, J. Estall, and D. J. Drucker Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase J. Biol. Chem., July 5, 2002; 277(28): 24896 - 24906. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Hsu, L. D. Shultz, X. Su, J. Shi, P.-A. Yang, M. J. Relyea, H.-G. Zhang, and J. D. Mountz Mutation of the Hematopoietic Cell Phosphatase (Hcph) Gene Is Associated with Resistance to {{gamma}}-Irradiation-Induced Apoptosis in Src Homology Protein Tyrosine Phosphatase (SHP)-1-Deficient ""Motheaten"" Mutant Mice J. Immunol., January 15, 2001; 166(2): 772 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-associated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor Cancer Res., January 1, 2001; 61(2): 687 - 693. [Abstract] [Full Text] |
||||
![]() |
D. Liu, G. Martino, M. Thangaraju, M. Sharma, F. Halwani, S.-H. Shen, Y. C. Patel, and C. B. Srikant Caspase-8-mediated Intracellular Acidification Precedes Mitochondrial Dysfunction in Somatostatin-induced Apoptosis J. Biol. Chem., March 24, 2000; 275(13): 9244 - 9250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Scott and N. S. Allen Changes in Cytosolic pH within Arabidopsis Root Columella Cells Play a Key Role in the Early Signaling Pathway for Root Gravitropism Plant Physiology, December 1, 1999; 121(4): 1291 - 1298. [Abstract] [Full Text] |
||||
![]() |
M. Thangaraju, K. Sharma, B. Leber, D. W. Andrews, S.-H. Shen, and C. B. Srikant Regulation of Acidification and Apoptosis by SHP-1 and Bcl-2 J. Biol. Chem., October 8, 1999; 274(41): 29549 - 29557. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yusta, R. P. Boushey, and D. J. Drucker The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway J. Biol. Chem., November 3, 2000; 275(45): 35345 - 35352. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |